The amino-terminal and carboxyl-terminal portions of the 1–34 fragment of parathyroid
hormone (PTH) contain the major determinants of receptor activation and receptor binding …

Recent mutagenesis and cross-linking studies suggest that residues in the carboxyl-terminal
portion of PTH (1–34) interact with the amino-terminal extracellular domain of the receptor …

Novel parathyroid hormone (PTH) peptides and analogs thereof of the PTH (1-34) fragment
are disclosed that com bine the N-terminal signaling domain (residues 1-9) and the C …

The present invention is related to novel Synthetic and/or recombinant biologically active
peptide derivatives of par athyroid hormone (PTH). In particular, the invention relates to PTH …

The present invention relates to conformationally constrained parathyroid hormone (PTH)
analogs, and methods of prepar ing and using the PTH analogs. The invention provides …

Novel parathyroid hormone (PTH) peptides and analogs thereof of the PTH (1-34) fragment
are disclosed that com bine the N-terminal signaling domain (residues 1-9) and the C …

US7479478B2 - Human parathyroid hormone modifications, preparation and use - Google
Patents US7479478B2 - Human parathyroid hormone modifications, preparation and use …

US6803213B2 - Nucleic acids encoding modified parathyroid hormone - Google Patents
US6803213B2 - Nucleic acids encoding modified parathyroid hormone - Google Patents …

Publisher Summary The biological actions of parathyroid hormone (PTH) and parathyroid
hormone-related protein (PTHrP) have attracted wider interest in recent years because of …

Novel parathyroid hormone (PTH) polypeptide derivatives are disclosed, as are
pharmaceutical compositions contain ing said polypeptides, and synthetic and recombinant …